Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Jefferies has reduced its price target for Tesla to $375 and cautioned that growing market belief in a potential Tesla-SpaceX merger could cause TSLA to trade as a proxy for SpaceX. The firm sees roughly 6% downside from current levels and projects below-consensus results as early investments in robotaxi and humanoid robot programs create initial l…
Shares of Getty Images jumped sharply in pre-market trading after the company announced a multi-year arrangement to integrate its licensed image libraries directly into OpenAI’s ChatGPT search and discovery experiences. The partnership, revealed on the evening of June 21, 2026, was cited by Getty’s CEO as a step to improve the usefulness and trustw…
When chipmakers and equipment manufacturers dominate headlines, the raw materials that underpin circuit boards can be overlooked. This month, a Hong Kong-based laminate and copper-foil producer vaulted into triple-digit monthly gains after announcing a large stake sale and a string of product price increases. The move highlights a broader market ro…
Morgan Stanley says Kevin Warsh’s first Federal Open Market Committee meeting helped rebuild market confidence in the Federal Reserve by signaling a renewed focus on inflation and less reliance on balance sheet tools. However, the firm cautions that reduced liquidity - driven by smaller reserve management purchases, lower Treasury buybacks and acce…
Indonesia's benchmark IDX Composite Index ended Monday's session lower, down 0.77%, pressured by losses across the Financials, Infrastructure and Agriculture sectors. Market breadth favored decliners, with 485 stocks falling versus 218 advancing and 152 unchanged. Several small- and mid-cap names posted outsized percentage moves in both directions,…
European government bond yields fell on Monday after the start of diplomatic talks between U.S. and Iranian negotiators eased some investor fear, while market participants also awaited guidance from European Central Bank officials later in the day. German 10-year yields moved lower, two-year German notes tracked shifts in ECB rate expectations, and…
Inficon shares surged to a fresh 52-week high after a broad rally in semiconductor stocks boosted demand for chip-equipment names. The Swiss vacuum-instrumentation firm rose to CHF 185.4, supported by earlier updates to 2026 guidance, analyst target increases and a sustained technical uptrend ahead of its July earnings date.
RWE is reported to be in talks to acquire roughly 31% of German transmission system operator Amprion, a move that would lift its stake to a controlling 51% and require full consolidation of Amprion into RWE's financial results. The deal would price Amprion at a single-digit premium to its 2026 Regulated Asset Base (RAB), a valuation level that is l…
BioArctic AB shares rose in Stockholm after the company announced a research and collaboration agreement with Eli Lilly to combine BioArctic’s BrainTransporter platform with an undisclosed Lilly drug candidate aimed at neurodegeneration. The deal includes $30 million upfront, up to $770 million in milestone payments and tiered mid-single digit roya…
Shares of Nordex climbed after the company announced three U.S. orders totalling 484 megawatts. Analyst commentary from Goldman Sachs and a risk-on market backdrop helped push the stock to session highs, bringing it close to its 52-week peak. Details on customer identities were not disclosed, and sector performance remained mixed.
Intel shares rose sharply in pre-market trading, extending a rally that started after a social media announcement linking the company with Apple on U.S. chip production. Additional momentum came from a higher analyst price target that cited advanced packaging opportunities and from CEO Lip-Bu Tan outlining an ambitious multi-year return objective. …
Lisi shares jumped sharply after Berenberg launched coverage with a high-conviction Buy recommendation and an €81 price target. The initiation, released before the Paris open, drove the stock to a session high of €72.60 - a new 52-week peak - before it settled near €70.50. The move comes alongside reported first-quarter 2026 revenue growth and the …
Apogee Therapeutics stock jumped 55.2% in pre-market trading after reports indicated AbbVie is close to announcing a $10.9 billion all-cash acquisition, a proposal that would value Apogee at about a 60% premium to its most recent close. Analysts highlighted the deal's strategic rationale and Apogee’s lead candidate, while recent institutional finan…
Amazon is trading $244.37 after a pullback from its highs. With AWS growing into an AI infrastructure leader, a market cap near $2.63T, and a PE around 29x, the stock looks priced for slower growth than the company can deliver. This trade idea outlines an actionable long with precise entry, stop and target and a 180-trading-day horizon.
Shares of French industrial group Lisi SA climbed more than 5% on Monday after Berenberg began coverage with a Buy rating and a €81 price target. The bank's case centers on Lisi's Aerospace division, which it describes as the company's standout business given a roughly 20% global share in aerospace fasteners and high structural barriers to competit…
Belimo stock slipped 1.8% to CHF 938 following a Jefferies downgrade from Buy to Hold, a move tied to elevated valuation rather than deterioration in company fundamentals. Jefferies raised its price target slightly to CHF 1,035 but flagged limited upside as the stock trades close to its 52-week high. Consensus expectations for solid first-half sale…
Swedish biotech BioArctic AB has struck a collaboration with Eli Lilly to merge BioArctic's BrainTransporter platform with a Lilly proprietary compound aimed at neurodegeneration. The arrangement includes a $30 million upfront payment, potential milestone payouts up to $770 million, and tiered mid-single digit royalties on future global sales, whil…
A European Central Bank study published June 22 reports that the rapid adoption of artificial intelligence in the United States has not produced a large aggregate decline in employment or wages through 2025. The ECB's Economic Bulletin finds that while some occupations face high substitution risk - and have seen employment falls - overall labour ha…
Umicore shares fell after Berenberg downgraded the stock from buy to hold, trimming price targets and lowering forecasts as the bank flagged a peak in cobalt prices, limited upside for precious metals amid a firmer Fed stance, and structural risk from the company's heavy automotive exposure. The move comes as U.S. equity markets rallied, suggesting…
EasyJet shares rose after Castlelake LP disclosed a £4.74 billion cash takeover offer at 625 pence per share following a string of private approaches that the airline's board had declined. The public disclosure is intended to give shareholders a chance to register their views ahead of a put-up-or-shut-up deadline set for 5pm London time on June 26,…
Citigroup and UBS have each lifted their projections for Taiwan's real GDP growth in 2026 to 9.9%, citing stronger-than-expected export momentum. The two banks diverge on inflation and interest-rate outlooks: Citi sees domestic inflation building and expects the central bank to start hiking rates in December, while UBS anticipates the central bank …
Carrefour shares climbed 1.6% to €15.80 after Morgan Stanley began coverage with an Overweight rating and a €20.10 price target, arguing the stock trades at about a 40% discount to 2028 earnings estimates. The bank forecasts roughly 11% annual EPS growth through 2028 and a free cash flow yield near 14%. Management’s June 2026 authorization of an 18…
Carrefour shares lifted after Morgan Stanley began coverage with an Overweight rating and a €20.10 price target, arguing the market has not yet fully reflected the retailer's recent strategic changes. The bank highlights improved free cash flow visibility, margin potential in France, a tighter European footprint and potential benefits from refinanc…
Johnson & Johnson ($JNJ) is a large-cap defensive compounder with a diversified MedTech and Innovative Medicine franchise, $17.4B in free cash flow, and a 2.3% yield. Recent positive Phase 3 data on TALVEY and continued margin resilience make JNJ an attractive buy to balance AI/concentrated-tech exposure. Initiate Buy with entry $228.40, target $26…
U.S. equity futures pared early declines after Iranian officials reported progress in talks with Washington, reducing immediate concerns about renewed Middle East escalation. Attention also stayed fixed on the artificial intelligence industry as President Trump softened his stance on Anthropic following export-control disputes, while SK Hynix surpa…
